Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Breast Cancer
Intervention:
Sponsor: Park Nicollet Institute
Recruiting - verified February 2010
Conditions: Crohn's Disease; Rheumatoid Arthritis
Intervention:
Sponsors: University of California, San Diego; Organization of Teratology Information Specialists (OTIS); Abbott
Recruiting - verified March 2010
Condition: Capsular Contractures
Intervention: Drug: Trental
Sponsor: Legacy Health System
Recruiting - verified March 2010
Condition: Breast Cancer
Intervention: Drug: Duloxetine
Sponsors: University of Michigan Cancer Center; Eli Lilly and Company
Recruiting - verified February 2010
Conditions: Neoplasms; Solid Tumors; Bone Cancer; Kidney Tumor; Neuroblastoma
Interventions: Drug: Temozolomide, Irinotecan, and SCH 717454; Drug: Vincristine, Doxorubicin, Cyclophosphamide (CAV), and SCH 717454; Drug: Ifosfamide, Etoposide (IE), and SCH 717454
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: Placebo; Drug: CP-690,550; Drug: Placebo; Drug: CP-690,550
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Cancer; Cataract; Low Bone Mineral Density; Osteopenia; Osteoporosis; Prostate Cancer
Interventions: Biological: Denosumab; Biological: Placebo
Sponsor: Amgen
Recruiting - verified March 2010
Conditions: Breast Cancer; Metastatic Cancer; Multiple Myeloma and Plasma Cell Neoplasm; Musculoskeletal Complications; Pain; Prostate Cancer; Urinary Complications
Intervention: Drug: zoledronic acid
Sponsors: Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Breast Cancer; Lung Cancer; Metastatic Cancer; Multiple Myeloma and Plasma Cell Neoplasm; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Procedure: assessment of therapy complications
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Hormone Refractory Prostate Cancer; Bone Metastases
Interventions: Drug: Alpharadin (Radium-223); Drug: Placebo
Sponsor: Algeta ASA
Recruiting - verified March 2009
Conditions: Breast Cancer; Osteoporosis
Interventions: Drug: exemestane; Other: biologic sample preservation procedure; Other: physiologic testing; Procedure: dual x-ray absorptometry
Sponsor: NCIC Clinical Trials Group
Recruiting - verified June 2009
Conditions: Advanced Cancer; Bone Metastases
Interventions: Procedure: Laser Ablation; Procedure: Magnetic Resonance Thermal Imaging
Sponsors: M.D. Anderson Cancer Center; BioTex, Inc.
Recruiting - verified March 2010
Conditions: Cancer; GCT; Giant Cell Tumor of Bone
Intervention: Drug: Denosumab
Sponsor: Amgen
Recruiting - verified March 2010
Conditions: Lymphedema; Musculoskeletal Complications; Radiation Fibrosis; Radiation Toxicity; Sarcoma
Interventions: Drug: chemotherapy; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Bone Cancer
Intervention: Drug: Dalteparin
Sponsors: M.D. Anderson Cancer Center; Pfizer
Recruiting - verified March 2010
Conditions: Osteoarthritis; Osteosarcoma; Scoliosis; Cerebral Palsy
Intervention:
Sponsor: University of Florida
Recruiting - verified February 2010
Conditions: Bone Neoplasms; Pain, Intractable; Cancer
Interventions: Drug: Pregabalin; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Bone Cancer; Sarcoma and Soft Tissue Cancers; Neoplasm Metastasis
Interventions: Procedure: F-18/F-18 FDG PET/CT; Procedure: Skeletal whole-body MRI; Procedure: Tc-99m MDP bone scan
Sponsor: Stanford University
Recruiting - verified February 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Osteoporosis; Ovarian Cancer; Testicular Germ Cell Tumor
Interventions: Dietary Supplement: calcium carbonate; Dietary Supplement: calcium citrate; Dietary Supplement: calcium glucarate; Dietary Supplement: cholecalciferol; Drug: calcium gluconate; Drug: zoledronic acid
Sponsors: Masonic Cancer Center, University of Minnesota; National Cancer Institute (NCI)
Recruiting - verified October 2008
Conditions: Hereditary Breast/Ovarian Cancer (brca1, brca2); Osteoporosis; Ovarian Cancer
Interventions: Drug: zoledronic acid; Other: clinical observation
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Sarcoma, Ewing's; Rhabdomyosarcoma; Soft Tissue Sarcoma; Musculoskeletal Tumors
Intervention: Procedure: Delivery of conformal limited margin radiotherapy
Sponsors: St. Jude Children's Research Hospital; Lance Armstrong Foundation
Recruiting - verified October 2009
Conditions: Growth Disorder; Mental Retardation; Multiple Abnormalies
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified March 2009
All Categories ... by Medical Condition » ... Cancers » ... Musculoskeletal 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
